Neurociencias
Departamento
Germán
Morís de la Tassa
Publicaciones en las que colabora con Germán Morís de la Tassa (17)
2024
-
Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry
Neuromuscular Disorders, Vol. 34, pp. 1-8
2022
-
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131
2020
-
Clinical and therapeutic features of myasthenia gravis in adults based on age at onset
Neurology, Vol. 94, Núm. 11, pp. e1171-e1180
2019
-
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585
-
PDGF-BB serum levels are decreased in adult onset Pompe patients
Scientific Reports, Vol. 9, Núm. 1
-
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
Movement Disorders, Vol. 34, Núm. 10, pp. 1547-1561
-
Reply to: “Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion”
Movement Disorders
-
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT
Molecular Genetics and Metabolism, Vol. 128, Núm. 1-2, pp. 129-136
2018
-
Drug-induced aseptic meningitis and other mimics
CNS Infections: A Clinical Approach: Second Edition (Springer International Publishing), pp. 275-300
-
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis
The Lancet Neurology, Vol. 17, Núm. 9, pp. 760-772
-
Quantitative muscle MRI to follow up late onset Pompe patients: A prospective study
Scientific Reports, Vol. 8, Núm. 1
2014
-
Drug-induced aseptic meningitis and other mimics
CNS Infections: A Clinical Approach (Springer-Verlag London Ltd), pp. 249-271
-
The challenge of drug-induced aseptic meningitis revisited
JAMA Internal Medicine
2013
-
SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V
Clinical Genetics, Vol. 83, Núm. 3, pp. 257-262
2012
-
Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegia
Journal of Neurology, Vol. 259, Núm. 2, pp. 246-250
2010
1999
-
The challenge of drug-induced aseptic meningitis
Archives of Internal Medicine, Vol. 159, Núm. 11, pp. 1185-1194